Tabitha W. Mahungu
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Evaluating the cost implications of integrating SARS-CoV-2 genome sequencing for infection prevention and control investigation of nosocomial transmission within hospitals.
Journal: The Journal of hospital infection
Published: March 08, 2023
Cross-sectional study evaluating the impact of SARS-CoV-2 variants on Long COVID outcomes in UK hospital survivors.
Journal: BMJ open respiratory research
Published: February 14, 2023
Low Risk of Failing Direct-Acting Antivirals in People With Human Immunodeficiency Virus/Hepatitis C Virus From Sub-Saharan Africa or Southeastern Asia: A European Cross-Sectional Study.
Journal: Open forum infectious diseases
Published: July 22, 2022
Effectiveness of rapid SARS-CoV-2 genome sequencing in supporting infection control for hospital-onset COVID-19 infection: Multicentre, prospective study.
Journal: eLife
Published: March 11, 2022
Comparative assessment of viral dynamic models for SARS-CoV-2 for pharmacodynamic assessment in early treatment trials.
Journal: British journal of clinical pharmacology
Published: February 11, 2022
Diagnostic accuracy of Abbott Architect Assay as a screening tool for human T-cell leukaemia virus type-1 and type-2 infection in a London teaching hospital with a large solid organ transplant centre.
Journal: Transfusion medicine (Oxford, England)
Published: October 12, 2021
The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital study.
Journal: The Journal of infection
Published: September 06, 2021
Evidence of the reduction of acute circulating communicable viruses during the SARS-CoV-2 pandemic in London.
Journal: The Journal of infection
Published: August 16, 2021
SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study.
Journal: BMJ open respiratory research
Published: June 21, 2021
The cytomegalovirus gB/MF59 vaccine candidate induces antibodies against an antigenic domain controlling cell-to-cell spread.
Journal: Nature communications
Published: June 11, 2021
Post-Vaccination Coronavirus Disease 2019: A Case-Control Study and Genomic Analysis of 119 Breakthrough Infections in Partially Vaccinated Individuals.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 02, 2021
Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK.
Journal: Emerging infectious diseases
Published: March 18, 2021
Last Updated: 09/26/2026